Abstract

Long-term (5 years) outcome of 30 patients whose aneurysm was excluded using the Parodi endograft (PE) was assessed. Thirty patients with a mean follow-up of 59 months were the basis of the analysis. Additionally, 100 consecutive patients treated with the Vanguard Endograft (VE) were followed up for 28 months (range, 7 to 56 months). Results were analyzed and both groups compared. There were no late failures related to the loss of the integrity of the device in the PE group. Aorto aortic systems showed distal neck dilatation in high proportion of patients (80%). Aorto-uni-iliac endograft was successful in 80% of the patients. Only one late type I endoleak developed in a patient in whom the proximal stent was placed far from the renal arteries and in contact with thrombus. Also, persistent type II endoleaks were the cause of failure. No neck dilatation was noted. In the VE group, most of the failures were device related.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call